Restriction analysis of influenza-specific cloned cell lines issued from an HLA-DRw6/DR- donor

Ghislaine Sterkers(Délégation Paris 7), J P Lévy(Hôpital Cochin), Jean Michon(Université Paris Sciences et Lettres), V. Lepage(Inserm), L Degos(Centre Hospitalier Universitaire de Lille), Jean‐Yves Muller(Institut National de la Transfusion Sanguine), Yvette Hénin(Centre National de la Recherche Scientifique)

Immunogenetics

January 1, 1984

10.1007/bf00430327

Cited by 4

Related Papers

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

|Nature Genetics|2015|563

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

|Blood|2006|431

All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia [see comments]

|Blood|1995|373

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

|Blood|2006|362

Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia

|Blood|1998|338